Jarosław Pająk

Jarosław Pająk

Auto-generated profile, based on publicly available information

Jarosław Pająk

Clinical Department of Oncological and Procreative Gynecology of the 4th Military Clinical Hospital with the Polyclinic, 50-981 Wrocław, Poland

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
JLJolanta Lis-Kuberka
Jolanta Lis-Kuberka
PKPaulina Kubik
Paulina Kubik
ACAgnieszka Chrobak
Agnieszka Chrobak
JPJarosław Pająk
Jarosław Pająk
ACAnna Chełmońska-Soyta
Anna Chełmońska-Soyta
MOMagdalena Orczyk-Pawiłowicz
Magdalena Orczyk-Pawiłowicz
The diagnosis of endometriosis and fertility disorders is difficult; therefore, it is necessary to look for reliable biomarkers. Analysis of the molecular status of fibronectin as a key player in repair and wound healing processes, as well as in coagulation and fibrinolysis pathways, is justified. ELISA and SDS-agarose immunoblotting were applied to determine the fibronectin concentration and presence and occurrence of soluble FN-fibrin complexes in the blood plasma of women with endometriosis (n = 38), fertility disorders (n = 28) and the healthy group (n = 25). The concentration of fibronectin in the blood plasma of women with endometriosis (292.61 ± 96.17 mg/L) and fertility disorders (287.53 ± 122.68 mg/L) was significantly higher than in the normal group (226.55 ± 91.98 mg/L). The presence of FN-fibrin complexes of 750, 1000, 1300, 1600 and 1900 kDa in the plasma of women with endometriosis and fertility disorders was shown. The presence of FN-fibrin complexes with a molecular mass of more than 1300 kDa in women with endometriosis and infertility and the complete absence of these complexes in healthy women may indicate an increased and chronic activation of coagulation mechanisms in these patients. The presence of complexes of high molecular mass may be one of the biomarkers of fertility disorders in women.